期刊
INTERNATIONAL JOURNAL OF GERONTOLOGY
卷 12, 期 3, 页码 261-263出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.ijge.2018.02.008
关键词
drug-induced liver injury; alzheimer's disease; anti-dementia drugs; elderly
资金
- Grants-in-Aid for Scientific Research [17K08966] Funding Source: KAKEN
Two patients with Alzheimer's disease who developed hepatitis caused by anti-dementia drugs are presented. Case 1: An 84-year-old-woman was referred to our hospital with profound jaundice. The levels of liver enzymes and jaundice decreased after the cessation of memantine and yokukansan (herbal medicine approved for dementia in Japan). Case 2: An 82-year-old-man was referred because of elevated transaminases. Liver biopsy showed central necrosis typical for drug-induced liver injury. The levels of transaminases decreased after withdrawal of rivastigmine transdermal patch treatment. Anti-dementia drugs have been safely used in terms of hepatotoxicity. However, some cases might be missed because of the difficulty in recognizing signs and symptoms in elderly and dementia patients. Copyright (C) 2018, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据